Wednesday, July 15, 2026

Kim Jong Un Oversees ‘Nuclear Trigger’ Drill in Latest Show of Force

Kim Jong Un oversaw a missile exercise to enhance North Korea's nuclear readiness, emphasizing the need for rapid response to threats.

The $2 BILLION Snub: Trump Dumps Denuclearization for a Photo-Op, Only to Be Humiliated By a Richer Kim Jong Un

Trump seeks to meet Kim Jong Un, but North Korea remains reserved, requiring clear benefits before engaging in dialogue.

Daewoong Pharmaceutical Expands Biosimilar Push With Dupixent Copy Deal and Global CDMO Partnership

Daewoong Pharmaceutical partners with Chime Biologics to develop a Dupixent biosimilar, enhancing its global biosimilar business expansion.

Tag: DongKoo Bio&Pharma

North KoreaKoreaKimMilitaryAISouth KoreamarketrelationsInternational

Dongkoo Bio&Pharma Invests 1 Billion KRW in GenomAndCompany: What This Means for ADC Drug Development

Dongkoo Bio&Pharma invests 1 billion KRW in Genome & Company to enhance antibody and ADC drug development strategies.

Discover the Future of Aesthetic Treatments: How Nanotechnology is Transforming the Beauty Industry

DongKoo Bio&Pharma partners with Supernova Bio and Areum Medics to innovate aesthetic treatments using advanced nanoparticle technology.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.